To address these issues and to advance technology, there is an urgent need for significant insights that can only come from a detailed molecular level understanding of the involved processes.
Designing rational therapies for treatment will have its foundation in the biologic understanding of involved genes and molecular pathways in these types of tumors.
Recent work suggests that the environment experienced in early life can alter life histories in wild populations [ 1 5], but our understanding of the processes involved remains limited [ 6, 7].
However, until now, most of the work in this field has been focused on the ligninolytic sub-system but, due to the great complexity of the involved processes, less progress has been made in understanding the biochemical regulatory structure that could explain growth dynamics, the substrate utilization and the ligninolytic system production itself.
Most of the involved processes are driven by microorganisms.
Indeed, existing MBR models are generally focused only on some of the involved processes (e.g. biological, physical, chemical, etc).
Detailed analysis shows that some of the involved processes can not be detected based on the expression data alone.
Phase four of the study involved processes of documentation, refinement and dissemination.
To counteract this process, a better understanding of the involved immune-physiological processes during pulmonary infections is needed to design more individualized approaches to the underlying disease.
